Determinations that Products Were Not Withdrawn From Sale for Reasons of Safety or Effectiveness: REV-EYES (Dapiprazole Hydrochloride Ophthalmic Solution), 0.5 Percent

Document ID: FDA-2012-P-1000-0004
Document Type: Notice
Agency: Food And Drug Administration
Topics: No Topics associated with this document
Federal Register Number: 2013-11285
View Document:  View as format pdf View as format html

Details Information

Document Subtype: General Notice
Received Date: May 13 2013, at 12:00 AM Eastern Daylight Time
Start-End Page: 27971 - 27971
Page Count: 1
Comment Start Date: May 13 2013, at 12:00 AM Eastern Standard Time

Comments

Total: 0
No comments posted.

Related Documents

Total: 0
No documents available.